Sacubitril/valsartan attenuates hypoxia/reoxygenation-induced cardiomyocyte injury by modulating macrophage polarization via TLR4/NF-κB pathway.

resatorvid (TAK-242) - Takeda, Akaza Bioscience

Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories

http://www.ncbi.nlm.nih.gov/pubmed/41965217

Bin Nie; Han Li; Lu Zhu; Nan Jin; Shifang Qu; Ying Qiu; Yulin Fang

Apr 12, 2026